Please provide your email address to receive an email when new articles are posted on . Despite recent increased adaptation of smaller catheters and radial access for coronary interventions, new ...
LEIPZIG, Germany—The US Food and Drug Administration has now approved the DETOUR System for the treatment of long, complex superficial femoropopliteal lesions, according to manufacturer Endologix.
MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results